Total Holdings
85
Portfolio diversification across 85 positions
SBIO
(NYSEARCA)ALPS Medical Breakthroughs ETF
$64.33-- (--)
Loading... - Market loading
SBIO ETF Holdings: ALPS Medical Breakthroughs ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$154.57M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
SS&C
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 47 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Alkermes plc | Stock | 4.88% |
| 2 |  | Kymera Therapeutics, Inc. | Stock | 4.69% |
| 3 |  | Spyre Therapeutics, Inc. | Stock | 4.31% |
| 4 |  | Mirum Pharmaceuticals, Inc. | Stock | 4.03% |
| 5 |  | CG Oncology, Inc. | Stock | 3.35% |
| 6 |  | Apogee Therapeutics, Inc. Common Stock | Stock | 3.27% |
| 7 |  | Travere Therapeutics, Inc. | Stock | 3.24% |
| 8 |  | Xenon Pharmaceuticals Inc | Stock | 2.87% |
| 9 |  | Celcuity LLC | Stock | 2.71% |
| 10 |  | Edgewise Therapeutics Inc | Stock | 2.47% |
| 11 |  | Dianthus Therapeutics Inc. | Stock | 2.41% |
| 12 |  | Crinetics Pharmaceuticals, Inc. | Stock | 2.41% |
| 13 |  | ACADIA Pharmaceuticals Inc | Stock | 2.38% |
| 14 |  | Denali Therapeutics Inc. | Stock | 2.29% |
| 15 |  | NewAmsterdam Pharma Company N.V. | Stock | 2.28% |
| 16 |  | Viking Therapeutics, Inc. | Stock | 2.25% |
| 17 |  | Oruka Therapeutics, Inc. | Stock | 2.24% |
| 18 |  | Structure Therapeutics Inc. American Depositary Shares | Stock | 2.01% |
| 19 |  | Relay Therapeutics, Inc. | Stock | 1.77% |
| 20 |  | IDEAYA Biosciences, Inc. | Stock | 1.76% |
| 21 |  | Disc Medicine, Inc. | Stock | 1.75% |
| 22 |  | Tarsus Pharmaceuticals Inc | Stock | 1.74% |
| 23 |  | Vera Therapeutics Inc | Stock | 1.62% |
| 24 |  | Celldex Therapeutics, Inc. | Stock | 1.41% |
| 25 |  | Pharvaris N.V. | Stock | 1.32% |
| 26 | G GLPG | Galapagos NV ADR | Stock | 1.26% |
| 27 |  | Zai Lab Limited | Stock | 1.26% |
| 28 |  | Vericel Corporation | Stock | 1.26% |
| 29 |  | Mineralys Therapeutics Inc. Common Stock | Stock | 1.24% |
| 30 |  | Rapport Therapeutics, Inc. Common Stock | Stock | 1.21% |
| 31 |  | Agios Pharmaceuticals, Inc | Stock | 1.14% |
| 32 |  | Nuvation Bio Inc | Stock | 1.13% |
| 33 |  | Stoke Therapeutics, Inc | Stock | 1.13% |
| 34 |  | Sionna Therapeutics, Inc. Common Stock | Stock | 1.07% |
| 35 |  | Sarepta Therapeutics, Inc | Stock | 1.06% |
| 36 |  | MBX | Stock | 1.05% |
| 37 |  | Taysha Gene Therapies, Inc | Stock | 1.03% |
| 38 |  | Palvella Therapeutics, Inc | Stock | 0.98% |
| 39 |  | Immunocore Holdings plc | Stock | 0.97% |
| 40 |  | Novavax, Inc | Stock | 0.96% |
| 41 |  | BCAX | Stock | 0.91% |
| 42 |  | ArriVent BioPharma, Inc. Common Stock | Stock | 0.89% |
| 43 |  | Immatics NV | Stock | 0.83% |
| 44 |  | Maze Therapeutics, Inc. Common Stock | Stock | 0.77% |
| 45 |  | MannKind Corp | Stock | 0.75% |
| 46 |  | Zenas BioPharma, Inc. Common Stock | Stock | 0.70% |
| 47 |  | Corvus Pharmaceuticals Inc | Stock | 0.66% |
Frequently Asked Questions About ALPS Medical Breakthroughs ETF Holdings
What are the top holdings in SBIO?
ALPS Medical Breakthroughs ETF (SBIO) holds 85 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is SBIO's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review SBIO's holdings table to analyze concentration risk.
What is SBIO's sector allocation?
The Sector Allocation chart shows how SBIO distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does SBIO invest in?
SBIO's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is SBIO ETF?
SBIO's diversification can be assessed by reviewing its 85 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.